Skip to main content
Dennis Choi, MD, Neurology, Stony Brook, NY

Dennis W Choi MD


Professor

Join to View Full Profile
  • retiredStony Brook, NY 11794

Dr. Choi is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical School
    Mass General Brigham/Brigham and Women's Hospital/Massachusetts General Hospital/Harvard Medical SchoolResidency, Neurology, 1982 - 1983
  • Beth Israel Deaconess Medical Center/Harvard Medical School
    Beth Israel Deaconess Medical Center/Harvard Medical SchoolResidency, Neurology, 1979 - 1982
  • Mass General Brigham/Brigham and Women's Hospital
    Mass General Brigham/Brigham and Women's HospitalInternship, Internal Medicine, 1978 - 1979
  • Harvard Medical School
    Harvard Medical SchoolClass of 1978

Certifications & Licensure

  • NH State Medical License
    NH State Medical License 2024 - 2026
  • NY State Medical License
    NY State Medical License 2012 - 2024
  • MO State Medical License
    MO State Medical License 2010 - 2016
  • GA State Medical License
    GA State Medical License 2008 - 2014
  • PA State Medical License
    PA State Medical License 2005 - 2008
  • Neurology
    American Board of Psychiatry and Neurology Neurology

Awards, Honors, & Recognition

  • Fellow American Association for the Advancement of Science, 2005
  • Fellow College of Physicians of Philadelphia, 2004
  • Christopher Reeve Research Medal Christopher and Dana Reeve Foundation, 1998
  • Join now to see all

Publications & Presentations

PubMed

Press Mentions

  • GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)
    GNT Pharma Provides Update on Two Phase III Studies of Nelonemdaz for Acute Ischemic Stroke Patients Treated with tPA (ENIS-3) or Endovascular Thrombectomy (RODIN)September 19th, 2022
  • Genes from over 5,000 Stroke Patients Hint at Surprising Treatment
    Genes from over 5,000 Stroke Patients Hint at Surprising TreatmentMay 8th, 2022
  • Calming Overexcited Neurons May Protect the Brain After a Stroke
    Calming Overexcited Neurons May Protect the Brain After a StrokeApril 26th, 2022
  • Join now to see all

Grant Support

  • Zinc And Ischemic Brain InjuryNational Institute Of Neurological Disorders And Stroke2000–2002
  • Excitotoxic Cell Death Of ES Derived Neural Lineage CellsNational Institute Of Neurological Disorders And Stroke2000–2002
  • Zinc NeurotoxicityNational Institute Of Neurological Disorders And Stroke2001
  • ES Cell Transplantation After Spinal Cord InjuryNational Institute Of Neurological Disorders And Stroke2000–2001
  • Cell-Cell Interaction And Hypoxic Brain InjuryNational Institute Of Neurological Disorders And Stroke2000
  • Nervous System Development And InjuryNational Institute Of Neurological Disorders And Stroke1997–2000
  • Glutamate Neurotoxicity In VitroNational Institute Of Neurological Disorders And Stroke1995–1999
  • Contribution Of AMPA/KA Receptor To Hypoxic Neuronal Injury In VitroNational Institute Of Neurological Disorders And Stroke1995–1999
  • Cell Cell Interaction And Hypoxic Brain InjuryNational Institute Of Neurological Disorders And Stroke1995–1999
  • 21ST Princeton Conference On Cerebrovascular DiseaseNational Institute Of Neurological Disorders And Stroke1997
  • Basic Neuroscience Training For Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1993–1996
  • Glutamate Neurotoxicity In Cortical Cell CultureNational Institute Of Neurological Disorders And Stroke1991–1994
  • Basic Clinical Neuroscience TrainingNational Institute Of Neurological Disorders And Stroke1992
  • Pharmacologic Reduction Of Hypoxic Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1991–1992
  • Pharmacologic Reduction Of Hypoxic Neuronal InjuryNational Institute Of Neurological Disorders And Stroke1988–1990
  • Glutamate Chemosensitivity Of Cortical NeuronsNational Institute Of Neurological Disorders And Stroke1985–1987

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: